{
    "title": "An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis.",
    "abst": "Proteinuria is an expected complication in transplant patients treated with mammalian target of rapamycin inhibitors (mTOR-i). However, clinical suspicion should always be supported by histological evidence in order to investigate potential alternate diagnoses such as acute or chronic rejection, interstitial fibrosis and tubular atrophy, or recurrent or de novo glomerulopathy. In this case we report the unexpected diagnosis of amyloidosis in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who developed proteinuria after conversion from tacrolimus to everolimus.",
    "title_plus_abst": "An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis. Proteinuria is an expected complication in transplant patients treated with mammalian target of rapamycin inhibitors (mTOR-i). However, clinical suspicion should always be supported by histological evidence in order to investigate potential alternate diagnoses such as acute or chronic rejection, interstitial fibrosis and tubular atrophy, or recurrent or de novo glomerulopathy. In this case we report the unexpected diagnosis of amyloidosis in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who developed proteinuria after conversion from tacrolimus to everolimus.",
    "pubmed_id": "24040781",
    "entities": [
        [
            59,
            70,
            "proteinuria",
            "Disease",
            "D011507"
        ],
        [
            84,
            94,
            "everolimus",
            "Chemical",
            "C107135"
        ],
        [
            96,
            98,
            "AL",
            "Disease",
            "D000686"
        ],
        [
            99,
            110,
            "amyloidosis",
            "Disease",
            "D000686"
        ],
        [
            112,
            123,
            "Proteinuria",
            "Disease",
            "D011507"
        ],
        [
            208,
            217,
            "rapamycin",
            "Chemical",
            "D020123"
        ],
        [
            422,
            430,
            "fibrosis",
            "Disease",
            "D005355"
        ],
        [
            443,
            450,
            "atrophy",
            "Disease",
            "D001284"
        ],
        [
            476,
            490,
            "glomerulopathy",
            "Disease",
            "D007674"
        ],
        [
            543,
            554,
            "amyloidosis",
            "Disease",
            "D000686"
        ],
        [
            670,
            681,
            "proteinuria",
            "Disease",
            "D011507"
        ],
        [
            704,
            714,
            "tacrolimus",
            "Chemical",
            "D016559"
        ],
        [
            718,
            728,
            "everolimus",
            "Chemical",
            "C107135"
        ]
    ],
    "split_sentence": [
        "An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis.",
        "Proteinuria is an expected complication in transplant patients treated with mammalian target of rapamycin inhibitors (mTOR-i).",
        "However, clinical suspicion should always be supported by histological evidence in order to investigate potential alternate diagnoses such as acute or chronic rejection, interstitial fibrosis and tubular atrophy, or recurrent or de novo glomerulopathy.",
        "In this case we report the unexpected diagnosis of amyloidosis in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who developed proteinuria after conversion from tacrolimus to everolimus."
    ],
    "if_txt_length_is_changed_flag": 0,
    "lines": [
        "D011507\tDisease\tproteinuria\tAn unexpected diagnosis in a renal-transplant patient with <target> proteinuria </target> treated with everolimus : AL amyloidosis .",
        "C107135\tChemical\teverolimus\tAn unexpected diagnosis in a renal-transplant patient with proteinuria treated with <target> everolimus </target> : AL amyloidosis .",
        "D000686\tDisease\tAL\tAn unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus : <target> AL </target> amyloidosis .",
        "D000686\tDisease\tamyloidosis\tAn unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus : AL <target> amyloidosis </target> .",
        "D011507\tDisease\tProteinuria\t<target> Proteinuria </target> is an expected complication in transplant patients treated with mammalian target of rapamycin inhibitors ( mTOR-i ) .",
        "D020123\tChemical\trapamycin\tProteinuria is an expected complication in transplant patients treated with mammalian target of <target> rapamycin </target> inhibitors ( mTOR-i ) .",
        "D005355\tDisease\tfibrosis\tHowever , clinical suspicion should always be supported by histological evidence in order to investigate potential alternate diagnoses such as acute or chronic rejection , interstitial <target> fibrosis </target> and tubular atrophy , or recurrent or de novo glomerulopathy .",
        "D001284\tDisease\tatrophy\tHowever , clinical suspicion should always be supported by histological evidence in order to investigate potential alternate diagnoses such as acute or chronic rejection , interstitial fibrosis and tubular <target> atrophy </target> , or recurrent or de novo glomerulopathy .",
        "D007674\tDisease\tglomerulopathy\tHowever , clinical suspicion should always be supported by histological evidence in order to investigate potential alternate diagnoses such as acute or chronic rejection , interstitial fibrosis and tubular atrophy , or recurrent or de novo <target> glomerulopathy </target> .",
        "D000686\tDisease\tamyloidosis\tIn this case we report the unexpected diagnosis of <target> amyloidosis </target> in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who developed proteinuria after conversion from tacrolimus to everolimus .",
        "D011507\tDisease\tproteinuria\tIn this case we report the unexpected diagnosis of amyloidosis in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who developed <target> proteinuria </target> after conversion from tacrolimus to everolimus .",
        "D016559\tChemical\ttacrolimus\tIn this case we report the unexpected diagnosis of amyloidosis in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who developed proteinuria after conversion from <target> tacrolimus </target> to everolimus .",
        "C107135\tChemical\teverolimus\tIn this case we report the unexpected diagnosis of amyloidosis in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who developed proteinuria after conversion from tacrolimus to <target> everolimus </target> ."
    ],
    "lines_lemma": [
        "D011507\tDisease\tproteinuria\tan unexpected diagnosis in a renal-transplant patient with <target> proteinuria </target> treat with everolimus : al amyloidosis .",
        "C107135\tChemical\teverolimus\tan unexpected diagnosis in a renal-transplant patient with proteinuria treat with <target> everolimus </target> : al amyloidosis .",
        "D000686\tDisease\tAL\tan unexpected diagnosis in a renal-transplant patient with proteinuria treat with everolimus : <target> AL </target> amyloidosis .",
        "D000686\tDisease\tamyloidosis\tan unexpected diagnosis in a renal-transplant patient with proteinuria treat with everolimus : al <target> amyloidosis </target> .",
        "D011507\tDisease\tProteinuria\t<target> Proteinuria </target> be an expect complication in transplant patient treat with mammalian target of rapamycin inhibitor ( mtor-i ) .",
        "D020123\tChemical\trapamycin\tProteinuria be an expected complication in transplant patient treat with mammalian target of <target> rapamycin </target> inhibitor ( mtor-i ) .",
        "D005355\tDisease\tfibrosis\thowever , clinical suspicion should always be support by histological evidence in order to investigate potential alternate diagnosis such as acute or chronic rejection , interstitial <target> fibrosis </target> and tubular atrophy , or recurrent or de novo glomerulopathy .",
        "D001284\tDisease\tatrophy\thowever , clinical suspicion should always be support by histological evidence in order to investigate potential alternate diagnosis such as acute or chronic rejection , interstitial fibrosis and tubular <target> atrophy </target> , or recurrent or de novo glomerulopathy .",
        "D007674\tDisease\tglomerulopathy\thowever , clinical suspicion should always be support by histological evidence in order to investigate potential alternate diagnosis such as acute or chronic rejection , interstitial fibrosis and tubular atrophy , or recurrent or de novo <target> glomerulopathy </target> .",
        "D000686\tDisease\tamyloidosis\tin this case we report the unexpected diagnosis of <target> amyloidosis </target> in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who develop proteinuria after conversion from tacrolimus to everolimus .",
        "D011507\tDisease\tproteinuria\tin this case we report the unexpected diagnosis of amyloidosis in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who develop <target> proteinuria </target> after conversion from tacrolimus to everolimus .",
        "D016559\tChemical\ttacrolimus\tin this case we report the unexpected diagnosis of amyloidosis in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who develop proteinuria after conversion from <target> tacrolimus </target> to everolimus .",
        "C107135\tChemical\teverolimus\tin this case we report the unexpected diagnosis of amyloidosis in a renal-transplant patient with pre-transplant monoclonal gammapathy of undetermined significance who develop proteinuria after conversion from tacrolimus to <target> everolimus </target> ."
    ]
}